Decision Aid: CSP vs Dual‑Chamber Leadless

Question

What would you recommend for a patient with a unicameral leadless pacemaker and nocturnal non‑capture given the following parameters: Age 71; LVEF 50%; NYHA I; complete (3°) AV block; atrial pacing need: possible; prior atrial flutter ablation (3 years ago); AV synchrony need: medium; nocturnal non‑capture: 7 nights/week; nocturnal capture threshold & safety margin: (value provided “300 V” appears implausible → treated as unknown); R‑wave amplitude 3 mV; day–night threshold delta: unknown; battery life ~4 years; syncope/presyncope: never; sleep apnea: never; resting nocturnal intrinsic HR 28 bpm; electrolytes abnormalities: never; nocturnal temperature drop >0.5 °C: no; meds affecting thresholds: no; renal function: good; infection risk: low; venous access: good; tricuspid regurgitation: none; future MRI needs: unlikely; anticoagulation: none; CRT/LBBB need: none; thoracic anatomy issues: none; patient preference: neutral; center CSP/dual‑leadless experience: high; cost/coverage constraints: moderate.

Summary (non‑medical)

Lean toward transvenous Conduction System Pacing (CSP), preferably LBBAP, based on the data provided and assuming goals of reliable AV activation and stable thresholds.

Patient Inputs (as provided)

Parameter	Value
Age	71
LVEF	50%
NYHA class	I
AV conduction	3° (complete) block
Atrial pacing need	Possible
History of AF/AFL	Atrial flutter ablation, 3 years ago
AV synchrony need	Medium
Nocturnal non-capture	7 nights/week
Nocturnal capture threshold	“300 V” as provided → treated as unknown
R-wave amplitude	3 mV
Day–night threshold delta	Unknown
Battery longevity	~4 years
Syncope/presyncope (30/90 d)	Never
Sleep apnea	Never
Intrinsic nocturnal HR (no capture)	28 bpm
Electrolyte abnormalities	Never
Nocturnal temp drop >0.5 °C	No
Meds affecting thresholds	No
Renal function (eGFR)	Good
Infection risk	Low
Venous access	Good
Tricuspid valve disease	None
Future MRI needs	Unlikely
Anticoagulation	None
CRT/LBBB need	None
Thoracic anatomy issues	None
Patient preference	Neutral
Center experience (CSP & dual-leadless)	High
Cost/coverage constraints	Moderate

Answer & Rationale

Short answer (educational, not medical advice): I would lean toward transvenous Conduction System Pacing (CSP), preferably left bundle branch area pacing (LBBAP), with moderate confidence. This is a decision-aid opinion to discuss with a qualified electrophysiologist.

Why CSP over dual-chamber leadless in this scenario

• 3° AV block requires robust AV activation. CSP (especially LBBAP) provides near-physiologic ventricular activation and typically offers lower, more stable capture thresholds than His-bundle pacing, helping battery economics.
• Nocturnal non-capture 7/7 nights with a unicameral leadless device suggests threshold vulnerability. Transvenous CSP tends to provide more stable thresholds and outputs than adding another intracardiac capsule.
• Operator/center experience is high – a major predictor of success and efficiency for CSP implantation and programming.
• Access and valve considerations are favorable: venous access is good, infection risk low, tricuspid regurgitation none – no strong impetus to avoid transvenous hardware.
• Synchrony need is “medium” and atrial pacing need only “possible” – CSP covers AV synchrony without necessarily requiring two leadless capsules.
• Cost/coverage is moderate – CSP is often less costly than maintaining/replacing multiple leadless capsules over time.

When a dual-chamber leadless system could still be reasonable

• If a strong preference to avoid transvenous hardware emerges.
• If venous access becomes limited/contraindicated, or infection risk increases substantially.
• If future evaluations show atrial sensing/pacing is consistently required and a fully leadless pathway offers reliable atrial–ventricular coordination for this patient.

Notes on provided inputs

• Nocturnal capture threshold “300 V” is not physiologically plausible for cardiac pacing outputs; treated as unknown. If available, please provide the threshold (V), pulse width (ms), and safety margin (V) to refine the analysis.
• Prior atrial flutter ablation (3 years ago) is noted but does not, by itself, favor dual-chamber leadless here.
• Missing/unknown: BMI and day–night threshold delta – assumed neutral.

Practical next steps to confirm the plan (for the EP team)

1. Quantify the day–night delta of capture thresholds and sensing (current device logs or temporary pacing assessment).
2. Screen again for sleep apnea; occult OSA can worsen nocturnal thresholds.
3. Re‑check electrolytes and consider core temperature monitoring on symptomatic nights.
4. If proceeding with CSP, favor LBBAP first for stable thresholds and battery longevity; reserve HBP when indicated and capture is robust.
5. If dual‑leadless remains on the table, ensure reliable atrial sensing/capture and verify that it would truly resolve the nocturnal threshold behavior.

Disclaimer: This page is an educational decision aid and does not constitute medical advice. Final device selection should be made by a qualified electrophysiologist with full access to the patient’s clinical data.